AIDS Medicines and Diagnostics Services - a network of organizations supporting access to HIV medicines and diagnostics J. Perriëns

Medicines Access to ARV in LMIC report + FB Increasing access to ARV in MIC Forecast of ARV demand Price benchmarks for ARVs in GPRM + summary report Price info for MIC HIV & HCV meds and diagnostics Regulatory status of ARVs Production capacity and price of ARV API Database on procurement of HIV and Hepatitis products* *(Additional data currently not included in the Global Price Reporting Mechanism)

Type date Medicines Challenges: Hepatitis C, hepatitis B infomediary Access to third line and pipeline HIV drugs Continuity of GPRM

Diagnostics – Rational procurement and deployment of diagnostics: "bundles" – global report + country feedback on CD4 and VL technology use – Diagnostics Access Initiative: forecasting – Price reporting ---> GPRM – SLIPTA in Africa and Europe – "normative" products

Diagnostics – Maintain support – at risk areas include: procurement guide inclusion of diagnostics in GPRM – Expand it to include hepatitis diagnostics support for VL roll out in Asia operational guidance on roll out of POC CD4 and VL technology